Pregled bibliografske jedinice broj: 438258
Novel amidino substituted 2-phenylbenzothiazoles : Synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo
Novel amidino substituted 2-phenylbenzothiazoles : Synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo // Bioorganic & medicinal chemistry, 18 (2010), 3; 1038-1044 doi:10.1016/j.bmc.2009.12.054 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 438258 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel amidino substituted 2-phenylbenzothiazoles : Synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo
Autori
Racané, Livio ; Kralj, Marijeta ; Šuman, Lidija ; Stojković, Ranko ; Tralić-Kulenović, Vesna ; Karminski-Zamola, Grace
Izvornik
Bioorganic & medicinal chemistry (0968-0896) 18
(2010), 3;
1038-1044
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
nitro-amidino- ; amino-amidino- and diamidino-substituted
Sažetak
The efficient synthesis of new bis-substituted nitro-amidino, amino-amidino (10a, 10b - 13a, 13b) and previously prepared diamidino 2-phenyl-benzothiazoles (9a, 9b) is described. The compounds 11a and 11b were prepared by recently developed methodology of the key precursors in zwitterionic form 8a and 8b with 4-nitrobenzoylchloride in a very good yield (70 %). All compounds except diamidino-substituted 2-phenylbenzothiazole 9a show exceptionally prominent tumor cell-growth inhibitory activity and cytotoxicity, whereby the special selectivity of amino-amidine 2-phenylbenzothiazole 12a towards MCF-7 and H 460 cells makes this compound a prospective lead compound that should be further evaluated in animal models. All in vivo tested compounds (12a, 12b, 13a and 13b) are absorbed from mice gastrointestinal system. LD50 are between 67.33 and 696.2 mg/kg body weight (OECD/EPA toxicity categories 2-3).
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
117-0000000-3283 - Istraživanje novih višenamjenskih bojila i optičkih bjelila (Racane, Livio, MZOS ) ( CroRIS)
098-0982464-2390 - Novi terapijski modaliteti u liječenju malignih bolesti (Stojković, Ranko, MZOS ) ( CroRIS)
125-0982464-1356 - Novi heterocikli kao antitumorski i antivirusni (pametni) lijekovi (Hranjec, Marijana, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Tekstilno-tehnološki fakultet, Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Vesna Tralić-Kulenović
(autor)
Livio Racane
(autor)
Lidija Šuman
(autor)
Ranko Stojković
(autor)
Grace Karminski-Zamola
(autor)
Marijeta Kralj
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE